Literature DB >> 26547583

The dual induction of apoptosis and autophagy by SZC014, a synthetic oleanolic acid derivative, in gastric cancer cells via NF-κB pathway.

Li Xiao Rui1, Song Yu Shu1, Wu Jing Jun1, Chen Zi Mo1, Sun Zheng Wu1, Liu Shu Min1, Lin Yuan1, Peng Jin Yong1, Song Zhi Cheng2, Wang Shi Sheng3, Tang Ze Yao4.   

Abstract

Oleanolic acid (OA) possesses various pharmacological activities, such as antitumor and anti-inflammation; however, its clinical applications are limited by its relatively weak activities and low bioavailability. In this study, we evaluated the cytotoxic activity of seven novel OA derivatives, one of which, SZC014 [2-(pyrrolidine-1-yl) methyl-3-oxo-olean-12-en-28-oic acid], exhibited the strongest antitumor activity; its anticancer effect on gastric cancer cells and action mechanisms were investigated. The viability of OA and seven synthesized derivatives treating gastric cancer cells was detected using tetrazolium (MTT). Among them, SZC014 exhibited the strongest cytotoxic activity against gastric cancer cells (SGC7901, MGC803, and MKN-45). The effect of SZC014 on cell cycle was identified by propidium iodide (PI) staining assay. The cellular apoptosis induced by SZC014 was tested by annexin V/PI. The cellular morphological changes and ultrastructural structures affected by SZC014 were observed and imaged through inverted phase contrast microscope and transmission electron microscopy. Western blotting was performed to explore the expression of proteins associated with apoptosis (caspase 3, caspase 9, Bax, Bcl-2, and Bcl-xL), autophagy (Beclin 1 and ATG 5), and nuclear factor-κB (NF-κB) signal pathway, respectively. The cytotoxic activities of all the seven synthesized OA derivatives were stronger than that of OA against gastric cancer cells. SZC014 exhibited stronger cytotoxic activity than other OA derivatives, inhibited the proliferation of gastric cancer cells, besides, induced G2/M phase cell cycle arrest in SGC7901 cells. Both apoptosis and autophagy were found simultaneously in SZC014-treated SGC7901 cells. Caspase-dependent apoptosis induced by SZC014 was confirmed to be associated with upregulation of Bax and downregulation of Bcl-2 and Bcl-xL, while upregulation of Beclin 1 and ATG 5 was inferred to be involved in SZC014-induced autophagy. Moreover, treating cells with SZC014 resulted in a decrease in phosphorylation of IκBα and NF-κB/p65 and NF-κB/p65 nuclear translocation. The cytotoxic activities of seven OA derivatives were generally stronger than that of OA, among which, SZC014 possessed the most potent anticancer activity in SGC7901 cells and would be a promising chemotherapic agent for the treatment of gastric cancer.

Entities:  

Keywords:  Apoptosis; Autophagy; Gastric cancer cells; NF-κB pathway; Oleanolic acid derivative; SZC014

Mesh:

Substances:

Year:  2015        PMID: 26547583     DOI: 10.1007/s13277-015-4293-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

1.  Anti-tumor activity of a 3-oxo derivative of oleanolic acid.

Authors:  Dan Huang; Yan Ding; Yan Li; Wenming Zhang; Weishuo Fang; Xiaoguang Chen
Journal:  Cancer Lett       Date:  2005-09-09       Impact factor: 8.679

2.  Oleanolic acid induces apoptosis of MKN28 cells via AKT and JNK signaling pathways.

Authors:  Yunmin Lu; Meiying Zhu; Wei Chen; Li Yin; Jinshui Zhu; Niwei Chen; Weixiong Chen
Journal:  Pharm Biol       Date:  2014-02-07       Impact factor: 3.503

3.  Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid.

Authors:  Ruth Chu; Xiaoyue Zhao; Chandi Griffin; Richard E Staub; Mark Shoemaker; Joan Climent; Dale Leitman; Isaac Cohen; Emma Shtivelman; Sylvia Fong
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

4.  Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells.

Authors:  Rongping Zhou; Zhongmin Zhang; Li Zhao; Chunhong Jia; Song Xu; Qiguang Mai; Ming Lu; Mingjun Huang; Liang Wang; Xiaokai Wang; Dadi Jin; Xiaochun Bai
Journal:  J Orthop Res       Date:  2011-01-18       Impact factor: 3.494

5.  Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (HIMOXOL), a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 breast cancer cells.

Authors:  Natalia Lisiak; Anna Paszel-Jaworska; Barbara Bednarczyk-Cwynar; Lucjusz Zaprutko; Mariusz Kaczmarek; Maria Rybczyńska
Journal:  Chem Biol Interact       Date:  2013-11-27       Impact factor: 5.192

6.  (24S)-ergostane-3β,5α,6β-triol from Hedyotis chrysotricha with inhibitory activity on migration of SK-HEP-1 human hepatocarcinoma cells.

Authors:  Miao Ye; Jing-Jing Su; Shu-Ting Liu; Lei Cao; Juan Xiong; Yun Zhao; Hui Fan; Guo-Xun Yang; Gang Xia; Jin-Feng Hu
Journal:  Nat Prod Res       Date:  2012-08-14       Impact factor: 2.861

7.  Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.

Authors:  Xin Wang; Hua Bai; Xiaodi Zhang; Jiangzheng Liu; Peipei Cao; Nai Liao; Wei Zhang; Zhao Wang; Chunxu Hai
Journal:  Carcinogenesis       Date:  2013-02-12       Impact factor: 4.944

8.  Targeting NFKB by autophagy to polarize hepatoma-associated macrophage differentiation.

Authors:  Chih-Peng Chang; Yu-Chi Su; Pei-Huan Lee; Huan-Yao Lei
Journal:  Autophagy       Date:  2013-01-29       Impact factor: 16.016

9.  Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo.

Authors:  Kelly Araújo Lúcio; Gleice da Graça Rocha; Leonardo Campos Monção-Ribeiro; Janaina Fernandes; Christina Maeda Takiya; Cerli Rocha Gattass
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

10.  The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma.

Authors:  Yefeng Yin; Xiulian Si; Yan Gao; Lei Gao; Jiangning Wang
Journal:  Oncol Rep       Date:  2012-10-19       Impact factor: 3.906

View more
  7 in total

Review 1.  Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.

Authors:  Elham Patrad; Solmaz Khalighfard; Taghi Amiriani; Vahid Khori; Ali Mohammad Alizadeh
Journal:  Cell Oncol (Dordr)       Date:  2022-09-23       Impact factor: 7.051

2.  Simulated ischemia/reperfusion-induced p65-Beclin 1-dependent autophagic cell death in human umbilical vein endothelial cells.

Authors:  Min Zeng; Xin Wei; Zhiyong Wu; Wei Li; Yin Zheng; Bing Li; Xuqing Meng; Xiuhong Fu; Yi Fei
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

3.  Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma.

Authors:  Rahel Mascha Stammer; Susann Kleinsimon; Jana Rolff; Sebastian Jäger; Angelika Eggert; Georg Seifert; Catharina I Delebinski
Journal:  J Immunol Res       Date:  2017-07-16       Impact factor: 4.818

4.  Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis.

Authors:  Bu-Gao Zhou; Hai-Mei Zhao; Xiu-Yun Lu; Xin Wang; Yong Zou; Rong Xu; Hai-Yang Yue; Yi Liu; Zheng-Yun Zuo; Duan-Yong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-30       Impact factor: 2.629

Review 5.  Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy.

Authors:  Lovro Žiberna; Dunja Šamec; Andrei Mocan; Seyed Fazel Nabavi; Anupam Bishayee; Ammad Ahmad Farooqi; Antoni Sureda; Seyed Mohammad Nabavi
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923

6.  Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats.

Authors:  Danyan Li; Luqing Zhao; Yuxin Li; Xiuhong Kang; Shengsheng Zhang
Journal:  Drug Des Devel Ther       Date:  2020-06-09       Impact factor: 4.162

7.  Ginsenoside CK, rather than Rb1, possesses potential chemopreventive activities in human gastric cancer via regulating PI3K/AKT/NF-κB signal pathway.

Authors:  Yan Wan; Dong Liu; Jia Xia; Jin-Feng Xu; Li Zhang; Yu Yang; Jiao-Jiao Wu; Hui Ao
Journal:  Front Pharmacol       Date:  2022-09-29       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.